Pfizer painkiller gets longer patent protection (Update)
Drugmaker Pfizer Inc. said Tuesday that a new patent on one of its top drugs, anti-inflammatory painkiller Celebrex, extends its U.S. patent protection by 18 months, potentially bringing the company a few billion dollars ...
Medications
Mar 05, 2013 |
not rated yet |
0
Bacteria and the bees: Antibiotics work better with honey
Medical-grade manuka honey (Medihoney), when used together with antibiotics, can both improve the effectiveness of the antibiotics and can prevent the emergence of resistance, according to new findings by ...
Medications
Mar 05, 2013 |
5 / 5 (3) |
0
India rejects Bayer plea against cheap cancer drug (Update)
India's patent appeals office has rejected Bayer AG's plea to stop the production of a cheaper generic version of a patented cancer drug in a ruling that health groups say is an important precedent for getting ...
Medications
Mar 05, 2013 |
5 / 5 (4) |
3
Pharmaceutical advertising down but not out, study says
The pharmaceutical industry has pulled back on marketing to physicians and consumers, yet some enduring patterns persist. According to a new study led by researchers at the Johns Hopkins Bloomberg School of Public Health, ...
Medications
Mar 04, 2013 |
not rated yet |
0
|
Bayer vows to fight for patent on anti-cancer drug in India
German pharmaceuticals giant Bayer, maker of Aspirin, vowed Monday to fight a ruling by the patent authorities in India allowing a local company to produce and sell a generic copy of its anti-cancer drug Nexavar.
Medications
Mar 04, 2013 |
not rated yet |
0
Pharmaceutical companies: An $84 million marketing effort in the District of Columbia
Drug companies spent nearly $84 million marketing pharmaceuticals in the District of Columbia in 2011, including an outlay of nearly $19 million for gifts given to physicians, hospitals and other health care providers, according ...
Medications
Mar 01, 2013 |
not rated yet |
0
Mining for new drugs in the ocean
Each time we use an antibiotic, the weaker strains of infection are killed off while the stronger, more virulent strains are left behind to multiply. In the past, this has not caused much concern, as there ...
Medications
Feb 28, 2013 |
not rated yet |
0
Top US court allows Amgen class action suit
The US Supreme Court ruled Wednesday in favor of investors seeking to join a class-action lawsuit against pharmaceutical giant Amgen for downplaying safety concerns about two anemia drugs.
Medications
Feb 28, 2013 |
not rated yet |
0
US drug firm Mylan to buy Indian firm for $1.6 bn
US generic drugs specialist Mylan said Thursday it would buy a unit of India's pharma firm Strides Arcolab for $1.6 billion, boosting its presence in the high-growth injectable drugs market.
Medications
Feb 27, 2013 |
not rated yet |
0
Most parents believe vaccines are safe for children, research finds
(Medical Xpress)—New research from the University of Adelaide shows that 95% of parents believe vaccines are safe for their children despite the spread of misinformation about vaccine safety.
Medications
Feb 27, 2013 |
not rated yet |
0
FDA approves drug for older women experiencing painful sex
(HealthDay)—The U.S. Food and Drug Administration has approved a new drug to treat postmenopausal women who experience pain during sex, the agency announced Tuesday.
Medications
Feb 26, 2013 |
not rated yet |
0
US halts Amgen study after teen patient death (Update)
U.S. government health regulators have halted Amgen's studies of its drug Sensipar after the death of a 14-year-old patient in a company trial.
Medications
Feb 26, 2013 |
not rated yet |
0
FDA: Omontys injection pulled from market
(HealthDay)—Affymax Inc. of Palo Alto, Calif., and Takeda Pharmaceuticals Company Limited of Deerfield, Ill., have voluntarily recalled all lots of Omontys Injection, used to treat anemia in adult dialysis ...
Medications
Feb 26, 2013 |
not rated yet |
0
FDA expands approval of Bayer cancer drug (Update)
The U.S. Food and Drug Administration on Monday expanded approval of a Bayer cancer pill to treat tumors of the intestinal tract that do not respond to other treatments.
Medications
Feb 25, 2013 |
not rated yet |
0
Risk of pancreatitis doubles for those taking new class of diabetes drugs
People who take the newest class of diabetes drugs to control blood sugar are twice as likely as those on other forms of sugar-control medication to be hospitalized with pancreatitis, Johns Hopkins researchers report.
Medications
Feb 25, 2013 |
5 / 5 (2) |
1
|
